Guest UserOffice of the Rt Hon. Andrea Leadsom MPOrkambi, Vertex, Matt Hancock MP, Cystic Fibrosis

Orkambi Agreement

Guest UserOffice of the Rt Hon. Andrea Leadsom MPOrkambi, Vertex, Matt Hancock MP, Cystic Fibrosis
Orkambi Agreement

I am absolutely delighted that the Health Secretary has announced today that NHS England has secured agreement with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines. I have a number of constituents whose children are CF sufferers, and who have campaigned tirelessly and bravely for this outcome; I am so pleased for them!

This agreement means NHS patients will now have full access to Orkambi, Symkevi and Kalydeco, and around 5000 people may now take up these treatments. There is no cap on patient numbers, and each and every patient in England who might benefit can now get these treatments, free on the NHS. Clinicians will be able to begin prescribing these drugs within 30 days.

This is a life-saving achievement and, on behalf of all my constituents living with cystic fibrosis, I would like to thank everyone who has campaigned for this to happen, as well as to Vertex and the NHS for reaching an agreement. It also wouldn’t have happened without the personal efforts of Matt Hancock, and his determination to see this through.

HealthGuest UserOffice of the Rt Hon. Andrea Leadsom MPout of hours healthcare, Nene Clinical Commissioning Group, Oxfordshire Clinical Commissioning Group, Julie Lemmy, Lou Patten, Kathryn Moody, Cllr Fiona Baker, 111, Brackley, Horton

Brackley Out of Hours Healthcare

HealthGuest UserOffice of the Rt Hon. Andrea Leadsom MPout of hours healthcare, Nene Clinical Commissioning Group, Oxfordshire Clinical Commissioning Group, Julie Lemmy, Lou Patten, Kathryn Moody, Cllr Fiona Baker, 111, Brackley, Horton
Brackley Out of Hours Healthcare
EU ReformGuest UserOffice of the Rt Hon. Andrea Leadsom MPUK Economy, Brexit, #DespiteBrexit, Brexit Britain, China, United States, CIty A.M., foreign direct investment, FDI, Forbes, Moody's Analytics, Mark Zandi, EU Referendum, IHS Markit, Eurozone, manufacturing, France, Germany, Italy, Europe, venture capital, tech sector, Graphcore, Microsoft, BMW, Nvidia, Intel, Google, unicorn, Monzo, Darktrace, Eileen Burbidge, Passion Capital, Tech Nation, fintech, space industry, Angus Horner, Harwell Space Cluster, satellites, life sciences, UCB, Roche, IQVIA, Life Sciences Sector Deal, Christie NHS Foundation Trust, Matt Hancock MP, Department for Health & Social Care, holidaymakers, tourism industry, Anna Friedrich, Christie & Co

Investment in Britain

EU ReformGuest UserOffice of the Rt Hon. Andrea Leadsom MPUK Economy, Brexit, #DespiteBrexit, Brexit Britain, China, United States, CIty A.M., foreign direct investment, FDI, Forbes, Moody's Analytics, Mark Zandi, EU Referendum, IHS Markit, Eurozone, manufacturing, France, Germany, Italy, Europe, venture capital, tech sector, Graphcore, Microsoft, BMW, Nvidia, Intel, Google, unicorn, Monzo, Darktrace, Eileen Burbidge, Passion Capital, Tech Nation, fintech, space industry, Angus Horner, Harwell Space Cluster, satellites, life sciences, UCB, Roche, IQVIA, Life Sciences Sector Deal, Christie NHS Foundation Trust, Matt Hancock MP, Department for Health & Social Care, holidaymakers, tourism industry, Anna Friedrich, Christie & Co
Investment in Britain